Literature DB >> 34029686

Effects of Vancomycin on Persistent Pain-Stimulated and Pain-Depressed Behaviors in Female Fischer Rats With or Without Voluntary Access to Running Wheels.

Emily Payne1, Kylee Harrington1, Philomena Richard1, Rebecca Brackin1, Ravin Davis1, Sarah Couture1, Jacob Liff1, Francesca Asmus1, Elizabeth Mutina1, Anyssa Fisher1, Denise Giuvelis2, Sebastien Sannajust2, Bahman Rostama3, Tamara King3, Lisa M Mattei4, Jung-Jin Lee4, Elliot S Friedman5, Kyle Bittinger4, Meghan May3, Glenn W Stevenson6.   

Abstract

The present experiments determined the effects of the narrow-spectrum antibiotic vancomycin on inflammatory pain-stimulated and pain-depressed behaviors in rats. Persistent inflammatory pain was modeled using dilute formalin (0.5%). Two weeks of oral vancomycin administered in drinking water attenuated Phase II formalin pain-stimulated behavior, and prevented formalin pain-depressed wheel running. Fecal microbiota transplantation produced a non-significant trend toward reversal of the vancomycin effect on pain-stimulated behavior. Vancomycin depleted Firmicutes and Bacteroidetes populations in the gut while having a partial sparing effect on Lactobacillus species and Clostridiales. The vancomycin treatment effect was associated with an altered profile in amino acid concentrations in the gut with increases in arginine, glycine, alanine, proline, valine, leucine, and decreases in tyrosine and methionine. These results indicate that vancomycin may have therapeutic effects against persistent inflammatory pain conditions that are distal to the gut. PERSPECTIVE: The narrow-spectrum antibiotic vancomycin reduces pain-related behaviors in the formalin model of inflammatory pain. These data suggest that manipulation of the gut microbiome may be one method to attenuate inflammatory pain amplitude.
Copyright © 2021 United States Association for the Study of Pain, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pain-depressed behaviors; amino acids; antibiotics; gut microbiome; rats; wheel running

Mesh:

Substances:

Year:  2021        PMID: 34029686      PMCID: PMC8578155          DOI: 10.1016/j.jpain.2021.05.003

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  72 in total

1.  Prior voluntary wheel running attenuates neuropathic pain.

Authors:  Peter M Grace; Timothy J Fabisiak; Suzanne M Green-Fulgham; Nathan D Anderson; Keith A Strand; Andrew J Kwilasz; Erika L Galer; Frederick Rohan Walker; Benjamin N Greenwood; Steven F Maier; Monika Fleshner; Linda R Watkins
Journal:  Pain       Date:  2016-09       Impact factor: 6.961

2.  Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.

Authors:  Bastiaan W Haak; Jacqueline M Lankelma; Floor Hugenholtz; Clara Belzer; Willem M de Vos; W Joost Wiersinga
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

3.  Home cage wheel running is an objective and clinically relevant method to assess inflammatory pain in male and female rats.

Authors:  Ram Kandasamy; Jonas J Calsbeek; Michael M Morgan
Journal:  J Neurosci Methods       Date:  2016-02-15       Impact factor: 2.390

4.  Engineering the gut microbiota to treat hyperammonemia.

Authors:  Ting-Chin David Shen; Lindsey Albenberg; Kyle Bittinger; Christel Chehoud; Ying-Yu Chen; Colleen A Judge; Lillian Chau; Josephine Ni; Michael Sheng; Andrew Lin; Benjamin J Wilkins; Elizabeth L Buza; James D Lewis; Yevgeny Daikhin; Ilana Nissim; Marc Yudkoff; Frederic D Bushman; Gary D Wu
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

5.  Wheel running improves REM sleep and attenuates stress-induced flattening of diurnal rhythms in F344 rats.

Authors:  Robert S Thompson; Rachel Roller; Benjamin N Greenwood; Monika Fleshner
Journal:  Stress       Date:  2016-04-28       Impact factor: 3.493

Review 6.  Sex, gender, and pain: a review of recent clinical and experimental findings.

Authors:  Roger B Fillingim; Christopher D King; Margarete C Ribeiro-Dasilva; Bridgett Rahim-Williams; Joseph L Riley
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

Review 7.  May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry.

Authors:  Eoin Sherwin; Kiran V Sandhu; Timothy G Dinan; John F Cryan
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

Review 8.  The Brain-Gut-Microbiome Axis.

Authors:  Clair R Martin; Vadim Osadchiy; Amir Kalani; Emeran A Mayer
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-04-12

Review 9.  Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health.

Authors:  Kaitlyn Oliphant; Emma Allen-Vercoe
Journal:  Microbiome       Date:  2019-06-13       Impact factor: 14.650

10.  Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritis.

Authors:  Giovanny Hernandez; Taylor S Mills; Jennifer L Rabe; James S Chavez; Susan Kuldanek; Gregory Kirkpatrick; Leila Noetzli; Widian K Jubair; Michelle Zanche; Jason R Myers; Brett M Stevens; Courtney J Fleenor; Biniam Adane; Charles A Dinarello; John Ashton; Craig T Jordan; Jorge Di Paola; James R Hagman; V Michael Holers; Kristine A Kuhn; Eric M Pietras
Journal:  Haematologica       Date:  2019-05-17       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.